This inventor holds 4 USPTO granted patents and 7 published patent applications and 3 EPO patents. Top assignees: Arecor Limited, Fresenius Kabi Deutschland Gmbh. Active years: 2022-2023.
Location History:
- Cambridge, GB (2022)
- Milton, GB (2022)
- Saffron Walden, GB (2023)
Company Filing History:
Years Active: 2022-2023
Title: The Innovations of Luca Badiali
Introduction
Luca Badiali is a notable inventor based in Milton, GB, recognized for his contributions to the field of pharmaceutical compositions. With a total of 4 patents, he has made significant strides in developing solutions that enhance the stability and efficacy of antibody proteins.
Latest Patents
Among his latest patents is the invention of stabilized antibody protein solutions. This patent provides an aqueous solution that includes an antibody protein and a stabilizing mixture of arginine, methionine, and a C3 polyol. Another significant patent is for a liquid pharmaceutical composition, which relates to novel formulations of adalimumab. This composition includes adalimumab or a biosimilar, EDTA, and a small polyol stabilizer such as glycerol. The combination of these components results in formulations that offer improved stability during storage and stress exposure, making adalimumab treatments more accessible and reducing waste from pre-filled delivery devices.
Career Highlights
Luca has worked with prominent companies in the pharmaceutical industry, including Arecor Limited and Fresenius Kabi Deutschland GmbH. His work in these organizations has contributed to advancements in drug formulation and delivery systems.
Collaborations
Luca has collaborated with notable professionals in his field, including David Gerring and Jan Jezek. These partnerships have fostered innovation and development in pharmaceutical technologies.
Conclusion
Luca Badiali's work exemplifies the impact of innovative thinking in the pharmaceutical industry. His patents not only enhance the stability of important medications but also aim to improve patient access to essential treatments.